PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2028120
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2028120
HBsAg Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of HBsAg testing Market
The global HBsAg testing market was valued at USD 1.44 billion in 2025 and is projected to grow to USD 1.53 billion in 2026, reaching USD 2.44 billion by 2034, exhibiting a CAGR of 6.07% during 2026-2034. North America dominated the market with a 38.89% share in 2025, supported by advanced diagnostic infrastructure and strong screening initiatives.
HBsAg (Hepatitis B Surface Antigen) testing plays a critical role in diagnosing hepatitis B infection by detecting viral antigens in the bloodstream. The growing global burden of hepatitis B, along with rising awareness and screening programs, is significantly boosting market demand.
Market Drivers
Rising Burden of Hepatitis B
The increasing prevalence of hepatitis B is a major factor driving demand for HBsAg testing. According to global health estimates, millions of people continue to live with chronic hepatitis B infections, creating a strong need for early diagnosis and monitoring. Increased transmission risks in healthcare settings and developing regions further accelerate testing demand.
Government Initiatives & Screening Programs
Governments and health organizations are actively promoting hepatitis B screening. Guidelines recommending routine testing-especially among pregnant women and adults-are increasing the number of tests conducted annually. Global elimination programs targeting hepatitis B by 2030 are further strengthening market growth.
Market Trends
Growing Adoption of Advanced Diagnostic Technologies
There is a rising demand for advanced testing techniques such as chemiluminescence immunoassays and rapid diagnostic tests. These technologies offer higher sensitivity, faster results, and improved efficiency, making them preferable in both laboratory and point-of-care settings.
Expansion of Point-of-Care Testing
The market is witnessing a shift toward point-of-care (POC) testing, enabling faster diagnosis in remote and low-resource settings. Additionally, digital health integration and home-based testing solutions are gaining traction, improving accessibility and convenience.
Market Restraints
Accuracy Limitations and False Results
HBsAg tests may sometimes produce false positives or false negatives due to sensitivity limitations or environmental conditions. These inaccuracies can affect diagnosis reliability and hinder widespread adoption.
Availability of Alternative Tests
The presence of alternative diagnostic methods such as anti-HBs and IgM anti-HBc tests may reduce reliance on HBsAg testing, thereby restraining market growth.
Market Opportunities
Increasing R&D for Innovative Testing Solutions
Market players and research institutions are investing heavily in developing advanced diagnostic tools, including self-testing kits and rapid assays. These innovations aim to improve early detection and expand testing accessibility globally.
Expansion in Emerging Markets
Developing regions present significant growth opportunities due to rising awareness, improving healthcare infrastructure, and increasing government initiatives for disease control.
Segmentation Analysis
By Type
The qualitative segment dominated the market with a 93.6% share in 2026, driven by its widespread use in initial screening and diagnosis. The quantitative segment is expected to grow steadily due to increasing chronic disease monitoring.
By Technique
The chemiluminescence immunoassay segment led with a 48.28% share in 2026, owing to its high sensitivity and efficiency. ELISA remains a strong alternative due to cost-effectiveness.
By Setting
The laboratory-based segment dominated with a 97.24% share in 2026, supported by the increasing number of diagnostic laboratories. However, point-of-care testing is expected to grow at a faster rate.
By Sample Type
The blood sample segment held 91.62% share in 2026, as blood testing remains the standard for hepatitis B diagnosis.
By End-user
Clinical laboratories led the market due to high testing volumes, while hospitals and clinics are expected to grow steadily.
Regional Insights
- North America: Valued at USD 0.56 billion in 2025 and USD 0.59 billion in 2026, driven by strong healthcare systems and government funding.
- Europe: Reached USD 0.45 billion in 2025 and USD 0.47 billion in 2026, supported by increasing screening programs.
- Asia Pacific: Valued at USD 0.17 billion in 2025 and USD 0.19 billion in 2026, expected to grow fastest due to high disease prevalence in countries like China and India.
- Latin America & Middle East & Africa: Showing steady growth due to improving healthcare access and awareness initiatives.
Competitive Landscape
Key players such as Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., and Abbott dominate the market. These companies focus on partnerships, acquisitions, and product innovation to strengthen their market position. Emerging players are also investing in rapid diagnostic technologies to expand their presence.
Conclusion
The HBsAg testing market is set for steady growth, increasing from USD 1.44 billion in 2025 to USD 2.44 billion by 2034, driven by the rising global burden of hepatitis B and strong government screening initiatives. Technological advancements, particularly in rapid and point-of-care testing, are reshaping the diagnostic landscape. However, challenges such as test inaccuracies and limited access in low-resource regions persist. Overall, with continuous innovation, expanding healthcare infrastructure, and global disease elimination efforts, the market is expected to witness sustained growth throughout the forecast period.
Segmentation By Type
- Qualitative
- Quantitative
By Technique
- Enzyme-linked immunosorbent Assay
- Chemiluminescence Immunoassay
- Chromatographic Immunoassay
By Setting
- Point of Care
- Laboratory-based
By Sample Type
- Blood
- Plasma
- Others
By End-user
- Hospitals & Clinics
- Clinical Laboratories
- Others
By Region
- North America (By Type, Technique, Setting, Sample Type, End-user, and Country)
- U.S.
- Canada
- Europe (By Type, Technique, Setting, Sample Type, End-user, and Country/Sub-region)
- U.K.
- Germany
- France
- Spain
- Italy
- Sweden
- Scandinavia
- Rest of Europe
- Asia Pacific (By Type, Technique, Setting, Sample Type, End-user, and Country/Sub-region)
- Japan
- China
- Australia
- India
- New Zealand
- Taiwan
- South Korea
- Singapore
- Hong Kong
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Type, Technique, Setting, Sample Type, End-user, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Type, Technique, Setting, Sample Type, End-user, and Country/Sub-region)
- South Africa
- GCC
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Incidence of Hepatitis B - by Key Countries, 2025
- 4.2. Pricing Analysis - By Key Countries, 2025
- 4.3. New Product Launches - by Key Players
- 4.4. Key Industry Development (Mergers, Acquisitions, and Partnerships)
- 4.5. Impact of COVID-19 on the Market
5. Global HBsAg Testing Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Type
- 5.1.1. Qualitative
- 5.1.2. Quantitative
- 5.2. Market Analysis, Insights and Forecast - By Technique
- 5.2.1. Chromatographic Immunoassay
- 5.2.2. Chemiluminescence Immunoassay
- 5.2.3. Enzyme-linked Immunosorbent Assay (ELISA)
- 5.3. Market Analysis, Insights and Forecast - By Setting
- 5.3.1. Point of Care
- 5.3.2. Laboratory-based
- 5.4. Market Analysis, Insights and Forecast - By Sample Type
- 5.4.1. Blood
- 5.4.2. Plasma
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast - By End-user
- 5.5.1. Hospitals & Clinics
- 5.5.2. Clinical Laboratories
- 5.5.3. Others
- 5.6. Market Analysis, Insights and Forecast - Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America
- 5.6.5. Middle East & Africa
6. North America HBsAg Testing Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Qualitative
- 6.1.2. Quantitative
- 6.2. Market Analysis, Insights and Forecast - By Technique
- 6.2.1. Chromatographic Immunoassay
- 6.2.2. Chemiluminescence Immunoassay
- 6.2.3. Enzyme-linked Immunosorbent Assay (ELISA)
- 6.3. Market Analysis, Insights and Forecast - By Setting
- 6.3.1. Point of Care
- 6.3.2. Laboratory-based
- 6.4. Market Analysis, Insights and Forecast - By Sample Type
- 6.4.1. Blood
- 6.4.2. Plasma
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast - By End-user
- 6.5.1. Hospitals & Clinics
- 6.5.2. Clinical Laboratories
- 6.5.3. Others
- 6.6. Market Analysis, Insights and Forecast - By Country
- 6.6.1. U.S.
- 6.6.2. Canada
7. Europe HBsAg Testing Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Qualitative
- 7.1.2. Quantitative
- 7.2. Market Analysis, Insights and Forecast - By Technique
- 7.2.1. Chromatographic Immunoassay
- 7.2.2. Chemiluminescence Immunoassay
- 7.2.3. Enzyme-linked Immunosorbent Assay (ELISA)
- 7.3. Market Analysis, Insights and Forecast - By Setting
- 7.3.1. Point of Care
- 7.3.2. Laboratory-based
- 7.4. Market Analysis, Insights and Forecast - By Sample Type
- 7.4.1. Blood
- 7.4.2. Plasma
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast - By End-user
- 7.5.1. Hospitals & Clinics
- 7.5.2. Clinical Laboratories
- 7.5.3. Others
- 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.6.1. U.K.
- 7.6.2. Germany
- 7.6.3. France
- 7.6.4. Italy
- 7.6.5. Spain
- 7.6.6. Sweden
- 7.6.7. Scandinavia
- 7.6.8. Rest of Europe
8. Asia Pacific HBsAg Testing Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Qualitative
- 8.1.2. Quantitative
- 8.2. Market Analysis, Insights and Forecast - By Technique
- 8.2.1. Chromatographic Immunoassay
- 8.2.2. Chemiluminescence Immunoassay
- 8.2.3. Enzyme-linked Immunosorbent Assay (ELISA)
- 8.3. Market Analysis, Insights and Forecast - By Setting
- 8.3.1. Point of Care
- 8.3.2. Laboratory-based
- 8.4. Market Analysis, Insights and Forecast - By Sample Type
- 8.4.1. Blood
- 8.4.2. Plasma
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast - By End-user
- 8.5.1. Hospitals & Clinics
- 8.5.2. Clinical Laboratories
- 8.5.3. Others
- 8.6. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. Australia
- 8.6.5. New Zealand
- 8.6.6. Taiwan
- 8.6.7. South Korea
- 8.6.8. Singapore
- 8.6.9. Hong Kong
- 8.6.10. Southeast Asia
- 8.6.11. Rest of Asia Pacific
9. Latin America HBsAg Testing Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Qualitative
- 9.1.2. Quantitative
- 9.2. Market Analysis, Insights and Forecast - By Technique
- 9.2.1. Chromatographic Immunoassay
- 9.2.2. Chemiluminescence Immunoassay
- 9.2.3. Enzyme-linked Immunosorbent Assay (ELISA)
- 9.3. Market Analysis, Insights and Forecast - By Setting
- 9.3.1. Point of Care
- 9.3.2. Laboratory-based
- 9.4. Market Analysis, Insights and Forecast - By Sample Type
- 9.4.1. Blood
- 9.4.2. Plasma
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast - By End-user
- 9.5.1. Hospitals & Clinics
- 9.5.2. Clinical Laboratories
- 9.5.3. Others
- 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.6.1. Brazil
- 9.6.2. Mexico
- 9.6.3. Rest of Latin America
10. Middle East & Africa HBsAg Testing Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Qualitative
- 10.1.2. Quantitative
- 10.2. Market Analysis, Insights and Forecast - By Technique
- 10.2.1. Chromatographic Immunoassay
- 10.2.2. Chemiluminescence Immunoassay
- 10.2.3. Enzyme-linked Immunosorbent Assay (ELISA)
- 10.3. Market Analysis, Insights and Forecast - By Setting
- 10.3.1. Point of Care
- 10.3.2. Laboratory-based
- 10.4. Market Analysis, Insights and Forecast - By Sample Type
- 10.4.1. Blood
- 10.4.2. Plasma
- 10.4.3. Others
- 10.5. Market Analysis, Insights and Forecast - By End-user
- 10.5.1. Hospitals & Clinics
- 10.5.2. Clinical Laboratories
- 10.5.3. Others
- 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.6.1. South Africa
- 10.6.2. GCC
- 10.6.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. CTK Biotech, Inc.
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Biopanda Reagents Ltd
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Avecon Healthcare Pvt. Ltd.
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Abbott
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Bio-Rad Laboratories, Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Siemens Healthcare Private Limited
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. F. Hoffmann-La Roche Ltd
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Elabscience Bionovation Inc.
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.1. CTK Biotech, Inc.
List of Tables
- Table 01: Global HBsAg Testing Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 02: Global HBsAg Testing Market Revenue (USD billion) Forecast, By Technique, 2021-2034
- Table 03: Global HBsAg Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
- Table 04: Global HBsAg Testing Market Revenue (USD billion) Forecast, By Sample Type, 2021-2034
- Table 05: Global HBsAg Testing Market Revenue (USD billion) Forecast, By End-user, 2021-2034
- Table 06: Global HBsAg Testing Market Revenue (USD billion) Forecast, By Region, 2021-2034
- Table 07: North America HBsAg Testing Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 08: North America HBsAg Testing Market Revenue (USD billion) Forecast, By Technique, 2021-2034
- Table 09: North America HBsAg Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
- Table 10: North America HBsAg Testing Market Revenue (USD billion) Forecast, By Sample Type, 2021-2034
- Table 11: North America HBsAg Testing Market Revenue (USD billion) Forecast, By End-user, 2021-2034
- Table 12: North America HBsAg Testing Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 13: Europe HBsAg Testing Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 14: Europe HBsAg Testing Market Revenue (USD billion) Forecast, By Technique, 2021-2034
- Table 15: Europe HBsAg Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
- Table 16: Europe HBsAg Testing Market Revenue (USD billion) Forecast, By Sample Type, 2021-2034
- Table 17: Europe HBsAg Testing Market Revenue (USD billion) Forecast, By End-user, 2021-2034
- Table 18: Europe HBsAg Testing Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
- Table 19: Asia Pacific HBsAg Testing Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 20: Asia Pacific HBsAg Testing Market Revenue (USD billion) Forecast, By Technique, 2021-2034
- Table 21: Asia Pacific HBsAg Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
- Table 22: Asia Pacific HBsAg Testing Market Revenue (USD billion) Forecast, By Sample Type, 2021-2034
- Table 23: Asia Pacific HBsAg Testing Market Revenue (USD billion) Forecast, By End-user, 2021-2034
- Table 24: Asia Pacific HBsAg Testing Market Revenue (USD billion) Forecast, By Country/Sub-
- Table 25: Latin America HBsAg Testing Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 26: Latin America HBsAg Testing Market Revenue (USD billion) Forecast, By Technique, 2021-2034
- Table 27: Latin America HBsAg Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
- Table 28: Latin America HBsAg Testing Market Revenue (USD billion) Forecast, By Sample Type, 2021-2034
- Table 29: Latin America HBsAg Testing Market Revenue (USD billion) Forecast, By End-user, 2021-2034
- Table 30: Latin America HBsAg Testing Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
- Table 31: Middle East & Africa HBsAg Testing Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 32: Middle East & Africa HBsAg Testing Market Revenue (USD billion) Forecast, By Technique, 2021-2034
- Table 33: Middle East & Africa HBsAg Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
- Table 34: Middle East & Africa HBsAg Testing Market Revenue (USD billion) Forecast, By Sample Type, 2021-2034
- Table 35: Middle East & Africa HBsAg Testing Market Revenue (USD billion) Forecast, By End-user, 2021-2034
- Table 36: Middle East & Africa HBsAg Testing Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
List of Figures
- Figure 01: Global HBsAg Testing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 02: Global HBsAg Testing Market Value Share (%), By Type, 2025 & 2034
- Figure 03: Global HBsAg Testing Market Value Share (%), By Technique, 2025 & 2034
- Figure 04: Global HBsAg Testing Market Value Share (%), By Setting, 2025 & 2034
- Figure 05: Global HBsAg Testing Market Value Share (%), By Sample Type, 2025 & 2034
- Figure 06: Global HBsAg Testing Market Value Share (%), By End-user, 2025 & 2034
- Figure 07: Global HBsAg Testing Market Value Share (%), By Region, 2025 & 2034
- Figure 08: North America HBsAg Testing Market Value (USD billion), by Type, 2025 & 2034
- Figure 09: North America HBsAg Testing Market Value Share (%), by Type, 2025
- Figure 10: North America HBsAg Testing Market Value (USD billion), by Technique, 2025 & 2034
- Figure 11: North America HBsAg Testing Market Value Share (%), by Technique, 2025
- Figure 12: North America HBsAg Testing Market Value (USD billion), by Setting, 2025 & 2034
- Figure 13: North America HBsAg Testing Market Value Share (%), by Setting, 2025
- Figure 14: North America HBsAg Testing Market Value (USD billion), by Sample Type, 2025 & 2034
- Figure 15: North America HBsAg Testing Market Value Share (%), by Sample Type, 2025
- Figure 16: North America HBsAg Testing Market Value (USD billion), by End-user, 2025 & 2034
- Figure 17: North America HBsAg Testing Market Value Share (%), by End-user, 2025
- Figure 18: North America HBsAg Testing Market Value (USD billion), by Country, 2025 & 2034
- Figure 19: North America HBsAg Testing Market Value Share (%), by Country, 2025
- Figure 20: Europe HBsAg Testing Market Value (USD billion), by Type, 2025 & 2034
- Figure 21: Europe HBsAg Testing Market Value Share (%), by Type, 2025
- Figure 22: Europe HBsAg Testing Market Value (USD billion), by Technique, 2025 & 2034
- Figure 23: Europe HBsAg Testing Market Value Share (%), by Technique, 2025
- Figure 24: Europe HBsAg Testing Market Value (USD billion), by Setting, 2025 & 2034
- Figure 25: Europe HBsAg Testing Market Value Share (%), by Setting, 2025
- Figure 26: Europe HBsAg Testing Market Value (USD billion), by Sample Type, 2025 & 2034
- Figure 27: Europe HBsAg Testing Market Value Share (%), by Sample Type, 2025
- Figure 28: Europe HBsAg Testing Market Value (USD billion), by End-user, 2025 & 2034
- Figure 29: Europe HBsAg Testing Market Value Share (%), by End-user, 2025
- Figure 30: Europe HBsAg Testing Market Value (USD billion), by Country/Sub-region, 2025 & 2034
- Figure 31: Europe HBsAg Testing Market Value Share (%), by Country/Sub-region, 2025
- Figure 32: Asia Pacific HBsAg Testing Market Value (USD billion), by Type, 2025 & 2034
- Figure 33: Asia Pacific HBsAg Testing Market Value Share (%), by Type, 2025
- Figure 34: Asia Pacific HBsAg Testing Market Value (USD billion), by Technique, 2025 & 2034
- Figure 35: Asia Pacific HBsAg Testing Market Value Share (%), by Technique, 2025
- Figure 36: Asia Pacific HBsAg Testing Market Value (USD billion), by Setting, 2025 & 2034
- Figure 37: Asia Pacific HBsAg Testing Market Value Share (%), by Setting, 2025
- Figure 38: Asia Pacific HBsAg Testing Market Value (USD billion), by Sample Type, 2025 & 2034
- Figure 39: Asia Pacific HBsAg Testing Market Value Share (%), by Sample Type, 2025
- Figure 40: Asia Pacific HBsAg Testing Market Value (USD billion), by End-user, 2025 & 2034
- Figure 41: Asia Pacific HBsAg Testing Market Value Share (%), by End-user, 2025
- Figure 42: Asia Pacific HBsAg Testing Market Value (USD billion), by Country/Sub-region, 2025 & 2034
- Figure 43: Asia Pacific HBsAg Testing Market Value Share (%), by Country/Sub-region, 2025
- Figure 44: Latin America HBsAg Testing Market Value (USD billion), by Type, 2025 & 2034
- Figure 45: Latin America HBsAg Testing Market Value Share (%), by Type, 2025
- Figure 46: Latin America HBsAg Testing Market Value (USD billion), by Technique, 2025 & 2034
- Figure 47: Latin America HBsAg Testing Market Value Share (%), by Technique, 2025
- Figure 48: Latin America HBsAg Testing Market Value (USD billion), by Setting, 2025 & 2034
- Figure 49: Latin America HBsAg Testing Market Value Share (%), by Setting, 2025
- Figure 50: Latin America HBsAg Testing Market Value (USD billion), by Sample Type, 2025 & 2034
- Figure 51: Latin America HBsAg Testing Market Value Share (%), by Sample Type, 2025
- Figure 52: Latin America HBsAg Testing Market Value (USD billion), by End-user, 2025 & 2034
- Figure 53: Latin America HBsAg Testing Market Value Share (%), by End-user, 2025
- Figure 54: Latin America HBsAg Testing Market Value (USD billion), by Country/Sub-region, 2025 & 2034
- Figure 55: Latin America HBsAg Testing Market Value Share (%), by Country/Sub-region, 2025
- Figure 56: Middle East & Africa HBsAg Testing Market Value (USD billion), by Type, 2025 & 2034
- Figure 57: Middle East & Africa HBsAg Testing Market Value Share (%), by Type, 2025
- Figure 58: Middle East & Africa HBsAg Testing Market Value (USD billion), by Technique, 2025 & 2034
- Figure 59: Middle East & Africa HBsAg Testing Market Value Share (%), by Technique, 2025
- Figure 60: Middle East & Africa HBsAg Testing Market Value (USD billion), by Setting, 2025 & 2034
- Figure 61: Middle East & Africa HBsAg Testing Market Value Share (%), by Setting, 2025
- Figure 62: Middle East & Africa HBsAg Testing Market Value (USD billion), by Sample Type, 2025 & 2034
- Figure 63: Middle East & Africa HBsAg Testing Market Value Share (%), by Sample Type, 2025
- Figure 64: Middle East & Africa HBsAg Testing Market Value (USD billion), by End-user, 2025 & 2034
- Figure 65: Middle East & Africa HBsAg Testing Market Value Share (%), by End-user, 2025
- Figure 66: Middle East & Africa HBsAg Testing Market Value (USD billion), by Country/Sub-region, 2025 & 2034
- Figure 67: Middle East & Africa HBsAg Testing Market Value Share (%), by Country/Sub-region, 2025
- Figure 68: Global HBsAg Testing Market Share (%), 2025
